Aptalis Pharmaceutical Technologies
100 Somerset Corporate Blvd
Bridgewater, NJ 08807
Website: www.AptalisPharmaceuticalTechnologies.com or www.AptalisPharmaTech.com

Aptalis Pharmaceutical Technologies (formerly Eurand Pharmaceutical Technologies) develops and manufactures differentiated oral pharmaceutical products using its broad range of proprietary technologies that offer bioavailability enhancement of poorly soluble drugs, custom release profiles, and taste-masking formulations for dosage forms including orally disintegrating tablets.

Through our collaboration agreements, we provide resources for the development of new product formulations, or licensing of existing prescription and OTC drugs.

We have a multinational infrastructure with integrated R&D and manufacturing facilities in the U.S. and Europe, allowing us to provide global solutions to companies in various regions around the world. Visit us at www.AptalisPharmaceuticalTechnologies.com

Aptalis Pharmaceutical Technologies has demonstrated expertise and proven success in oral drug formulation using its proprietary drug delivery technologies, categorized in three platforms: Customized Drug Release, Bioavailability Enhancement, and Taste Masking for ODTs (orally disintegrating tablets) and other dosage forms. To learn more about our capabilities and to partner with us,  visit us in Madrid at CPHI – Booth #4B76 and speak with one of our licensing representatives.  Ask about how you can “Experience the Power of 3” and enter for a chance to win an iPAD^® or a Kindle^™

Aptalis Pharmaceutical Technologies Company Overview: Merged Companies Make Way for Aptalis Pharma Brand

Aptalis Product list